Open-label randomized multicenter study of once daily antiretroviral treatment regimen comparing ritonavir boosted atazanavir to efavirenz.
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2015
At a glance
- Drugs Atazanavir/ritonavir (Primary) ; Atazanavir; Efavirenz; Lamivudine/abacavir; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- 27 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 01 Mar 2011 New source identified and integrated (University Hospital Medical Information Network - Japan record C000000243).
- 23 Oct 2007 Status changed from recruiting to in progress.